恒瑞医药(01276.HK)午盘涨超14%，公司SHR-2173注射液获批临床。
2025-07-09 05:11:41
恒瑞医药(01276.HK)午盘涨超14%，公司SHR-2173注射液获批临床。
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
OPEC+已放下“手术刀”，拿起“三叉戟”，不再是小心翼翼地调控价格，而是猛力争抢市场份额。点击查看...Next article：
小丑竟是自己？欧盟曾嘲笑英国仓促与美国签约，如今却发现自己拿到的协议似乎比英国更差……点击查看...
